Overview |
bsm-54760R |
PLAP Monoclonal Antibody |
IHC-P |
Human |
Specifications |
Unconjugated |
Rabbit |
Synthetic peptide within N terminal Human PLAP. |
Monoclonal |
8H13 |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 1xTBS (pH7.4), 1%BSA, 40%Glycerol and 0.05% Sodium Azide. |
Store at -20°C for 12 months. |
Target |
9373 |
Q9Y263 |
Cytoplasm, Nucleus, Synapse |
FLJ11281 antibody, FLJ12699 antibody, Glycerophosphatase antibody, OTTHUMP00000045176 antibody, Phospholipase A 2 activating protein antibody, Phospholipase A-2-activating protein antibody, Phospholipase A2 activating protein antibody, PLA2P antibody, Plaa antibody, PLAP antibody, PLAP_HUMAN antibody |
Phospholipase A2 activator protein (PLAP), activates PLA2 (phospholipase A2 enzyme) and is an important mediator of eicosanoid generation. Also known as a pro-inflammatory agent, PLAP has been found in inflamed tissues and synovial fluid from patients with rheumatoid arthritis. As such, it is believed to play an important role in the regulation of inflammatory diseases. The formation of PLAP can be stimulated by IL-1 beta and TNF-alpha. |
Application Dilution |
IHC-P |
1:200-400 |